We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fast, Accurate Assay Differentiates Between Campylobacter Species

By HospiMedica staff writers
Posted on 12 Feb 2007
A real-time polymerase chain reaction (PCR) assay differentiates between three species of Campylobacter.

Most current screening procedures for Campylobacter are culture-based, take at least three days for a result, and do not differentiate between species without additional investigational work. More...
The new Bax assay differentiates between the pathogenic species C jejuni, C coli, and C lari, and quantifies them. Results for highly contaminated samples (direct protocol) are available the same day, and take up to 48 hours for samples requiring enrichment

Oxoid Limited (Basingstoke, UK), marketing partner for the DuPont Qualicon Bax System in Europe, Australia, and Canada, launched the new Bax real-time PCR assay for Campylobacter. PCR is a method used for amplifying and detecting specific DNA in a sample. The Bax real-time Campylobacter assay, the first in a series of new real-time assays from DuPont Qualicon, uses PCR and probe-based chemistry to detect, quantify, and differentiate between these three species of Campylobacter in the same sample.

Target-specific probes (linked with different fluorescent markers) are displaced and cleaved from their target DNA during the amplification process, resulting in an increase in fluorescence. This fluorescence is measured at the end of each amplification cycle in real time. The system is simple and easy to use. Lysis is straight-forward and requires no additional equipment. All reagents required for PCR are supplied in a single tablet conveniently packaged inside the PCR tubes provided in each kit. Tableted reagents minimize the amount of hands-on time required for processing whilst simultaneously simplifying and standardizing the procedure. Results are interpreted automatically and are ready for reporting. If necessary, icons and graphs make further result interrogation simple and easy to visualize.

Campylobacter infection is a worldwide public health concern and is the leading cause of enteric illness in many countries. Campylobacter species differ from other food pathogens in that they do not multiply within the food. However, as few as 500 cells are sufficient to cause infection. The organism is endemic in many poultry populations and whilst normally responsible for self-limiting enteritis, infection in man can lead to severe complications such as arthritis and Guillain-Barré syndrome, an acute paralytic disease of the nervous system. Although C jejuni is responsible for approximately 90% of infections, C coli and C lari have also been implicated.




Related Links:
Oxoid

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.